Pancreatic cancer is now among the most prevalent types of cancer in the US. The disease carries a very poor prognosis for survival and the majority of patients succumb to the disease within months of diagnosis. VeroScience has developed a unique and effective therapy to target pancreatic cancer without major side effects in animal models of the disease.
